CY1110487T1 - Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων - Google Patents

Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων

Info

Publication number
CY1110487T1
CY1110487T1 CY20091100694T CY091100694T CY1110487T1 CY 1110487 T1 CY1110487 T1 CY 1110487T1 CY 20091100694 T CY20091100694 T CY 20091100694T CY 091100694 T CY091100694 T CY 091100694T CY 1110487 T1 CY1110487 T1 CY 1110487T1
Authority
CY
Cyprus
Prior art keywords
controlled
overtraction
overseased
coh
day
Prior art date
Application number
CY20091100694T
Other languages
English (en)
Inventor
Stephen Hillier
Colin Michael Howles
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110487(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of CY1110487T1 publication Critical patent/CY1110487T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η ευρεσιτεχνία παρέχει μια καινοτόμο χρήση για την LH και τα ανάλογα, που έχουν LH-ενεργότητα, για την υποβοήθηση της ωοθυλακιογένεσης σε ελεγχόμενη υπερδιέγερση των ωοθηκών (COH), στην οποία η LH ή ένα ανάλογο αυτής, χορηγείται κατά την διάρκεια μιας περιόδου εκκίνησης, η οποία διαρκεί από την 1η ημέρα έως περίπου την 4η ημέρα της φάσης διέγερσης στην COH.
CY20091100694T 2001-09-12 2009-06-30 Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων CY1110487T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12
EP02767637A EP1434600B1 (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
CY1110487T1 true CY1110487T1 (el) 2015-04-29

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100694T CY1110487T1 (el) 2001-09-12 2009-06-30 Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων

Country Status (28)

Country Link
US (1) US7341989B2 (el)
EP (1) EP1434600B1 (el)
JP (1) JP2005504072A (el)
KR (1) KR20040032953A (el)
CN (1) CN1302806C (el)
AR (1) AR036591A1 (el)
AT (1) ATE427755T1 (el)
AU (1) AU2002331939B2 (el)
BR (1) BR0212502A (el)
CA (1) CA2457067A1 (el)
CY (1) CY1110487T1 (el)
DE (1) DE60231892D1 (el)
DK (1) DK1434600T3 (el)
EA (1) EA009210B1 (el)
ES (1) ES2322136T3 (el)
HK (1) HK1067866A1 (el)
HR (1) HRP20040070A2 (el)
IL (1) IL160781A0 (el)
ME (1) MEP38808A (el)
MX (1) MXPA04002125A (el)
NO (1) NO327154B1 (el)
PL (1) PL205472B1 (el)
PT (1) PT1434600E (el)
RS (1) RS51505B (el)
SI (1) SI1434600T1 (el)
UA (1) UA78970C2 (el)
WO (1) WO2003022301A2 (el)
ZA (1) ZA200401008B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530818A (ja) * 2002-06-07 2005-10-13 アレス トレーディング ソシエテ アノニム 卵巣過剰刺激の制御方法及び当該方法に利用する医薬キット
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
DK1176976T4 (en) 1999-05-07 2015-11-02 Serono Lab Use of LH administered mid- or senfollikelfase for the treatment of anovulatory women

Also Published As

Publication number Publication date
US20050049199A1 (en) 2005-03-03
JP2005504072A (ja) 2005-02-10
HK1067866A1 (en) 2005-04-22
EA200400428A1 (ru) 2004-08-26
US7341989B2 (en) 2008-03-11
SI1434600T1 (sl) 2009-06-30
IL160781A0 (en) 2004-08-31
NO327154B1 (no) 2009-05-04
WO2003022301A2 (en) 2003-03-20
ATE427755T1 (de) 2009-04-15
NO20040990L (no) 2004-03-08
BR0212502A (pt) 2004-08-24
MEP38808A (en) 2011-02-10
CA2457067A1 (en) 2003-03-20
PT1434600E (pt) 2009-04-28
EA009210B1 (ru) 2007-12-28
EP1434600A2 (en) 2004-07-07
CN1553809A (zh) 2004-12-08
HRP20040070A2 (en) 2004-10-31
RS51505B (sr) 2011-06-30
EP1434600B1 (en) 2009-04-08
AR036591A1 (es) 2004-09-22
UA78970C2 (uk) 2007-05-10
WO2003022301A3 (en) 2003-04-17
YU21204A (sh) 2006-08-17
ES2322136T3 (es) 2009-06-17
PL367343A1 (en) 2005-02-21
CN1302806C (zh) 2007-03-07
PL205472B1 (pl) 2010-04-30
ZA200401008B (en) 2005-08-31
AU2002331939B2 (en) 2007-10-25
KR20040032953A (ko) 2004-04-17
DE60231892D1 (de) 2009-05-20
MXPA04002125A (es) 2004-07-08
DK1434600T3 (da) 2009-05-25

Similar Documents

Publication Publication Date Title
CY1110487T1 (el) Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
CL2003001743A1 (es) Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida
CY1108578T1 (el) Φαρμακευτικες συνθεσεις (κιτ) περιλαμβανοντας ενωσεις διϋδροπυριδινονης και εναν ανοσορυθμιστικο (ή εναν αντιφλεγμονωδη) παραγοντα και οι χρησεις αυτων
NO20031018D0 (no) Oksymorfonpreparater med kontrollert frigivelse
ATE446758T1 (de) Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
CY1105517T1 (el) 2-oxo-1-pyrrolidine παραγωγο και οι φαρμακευτικες του χρησεις
CY1111872T1 (el) Συνθεσεις υποτασικου λιπιδιου (προσταγλανδινης) και τιμολολης - σχετικες μεθοδοι χρησης
CY1108041T1 (el) Αναστολεις της rho-κινασης
DE59101613D1 (de) Knochennagel zur Versorgung von Oberarmfrakturen.
ITMI20010562A1 (it) Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari
CY1112962T1 (el) 1,2-διαρυλο βενζιμιδαζολες για την αντιμετωπιση ασθενειων, οι οποιες σχετιζονται με την ενεργοποιηση μικρογλοιων
HUP0302026A2 (hu) Növekedési hormon szekrécióját fokozó triptofánszármazékok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69814394D1 (de) Verwendung von levobupivacain
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
NO882239D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
ATE177843T1 (de) Peptomere mit erhöhter immunogenizität
DE69330268T2 (de) Hämoregulierende peptide
BR0212447A (pt) Uso de hcg e lh na hiperestimulação ovariana controlada
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
ATE353693T1 (de) Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme
IT1241456B (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat